Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors:: Receptor subtype selectivity via cooperativity rather than affinity

被引:86
作者
Lazareno, S
Dolezal, V
Popham, A
Birdsall, NJM
机构
[1] MRC Technol, London NW7 1AD, England
[2] Acad Sci Czech Republ, Inst Physiol, Dept Neurochem, Prague, Czech Republic
[3] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England
关键词
D O I
10.1124/mol.65.1.257
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Thiochrome (2,7-dimethyl-5H-thiachromine-8-ethanol), an oxidation product and metabolite of thiamine, has little effect on the equilibrium binding of L-[H-3]N-methyl scopolamine ([H-3]NMS) to the five human muscarinic receptor subtypes (M-1 M-5) at concentrations up to 0.3 mM. In contrast, it inhibits [H-3]NMS dissociation from M-1 to M4 receptors at submillimolar concentrations and from M-5 receptors at 1 mM. These results suggest that thiochrome binds allosterically to muscarinic receptors and has approximately neutral cooperativity with [H-3]NMS at M-1 to M-4 and possibly M-5 receptors. Thiochrome increases the affinity of acetylcholine (ACh) 3- to 5-fold for inhibiting [H-3]NMS binding to M-4 receptors but has no effect on ACh affinity at M-1 to M-3 or M-5 receptors. Thiochrome (0.1 mM) also increases the direct binding of [H-3]ACh to M-4 receptors but decreases it slightly at M-2 receptors. In agreement with the binding data, thiochrome does not affect the potency of ACh for stimulating the binding of guanosine 5'-O-(3-[S-35]thiotriphosphate) ([S-35]GTPgammaS) to membranes containing M-1 to M-3 receptors, but it increases ACh potency 3.5-fold at M-4 receptors. It also selectively reduces the release of [H-3]ACh from potassium-stimulated slices of rat striatum, which contain autoinhibitory presynaptic M-4 receptors, but not from hippocampal slices, which contain presynaptic M-2 receptors. We conclude that thiochrome is a selective M-4 muscarinic receptor enhancer of ACh affinity and has neutral cooperativity with ACh at M-1 to M-3 receptors; it therefore demonstrates a powerful new form of selectivity, "absolute subtype selectivity", which is derived from cooperativity rather than from affinity.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 28 条
[1]
ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173
[2]
Detection and modulation of acetylcholine release from neurites of rat basal forebrain cells in culture [J].
Allen, TGJ ;
Brown, DA .
JOURNAL OF PHYSIOLOGY-LONDON, 1996, 492 (02) :453-466
[3]
Birdsall NJM, 1999, MOL PHARMACOL, V55, P778
[4]
BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469
[5]
Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery [J].
Christopoulos, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) :198-210
[6]
DOLEZAL V, 1992, N-S ARCH PHARMACOL, V345, P16
[7]
Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum [J].
Dolezal, V ;
Tucek, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (07) :1627-1632
[8]
The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists [J].
Dolezal, V ;
Tucek, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) :1213-1218
[9]
EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
[10]
Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: Synthesis and structure-affinity and cooperativity relationships [J].
Gharagozloo, P ;
Lazareno, S ;
Miyauchi, M ;
Popham, A ;
Birdsall, NJM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (06) :1259-1274